Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study

Osteoprotegerin, a potent osteoclast activation inhibitor, decreases bone resorption and positively affects bone mineral density. This study examined the association between serum osteoprotegerin levels and bone loss in patients with chronic kidney disease, a condition associated with increased risk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS One
Hauptverfasser: Kim, Chang Seong, Bae, Eun Hui, Ma, Seong Kwon, Han, Seung Hyeok, Choi, Kyu Hun, Lee, Joongyub, Chae, Dong Wan, Oh, Kook-Hwan, Ahn, Curie, Kim, Soo Wan
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2016
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5113973/
https://ncbi.nlm.nih.gov/pubmed/27855207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0166792
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge